Cisplatin

Cisplatin


CISPLATIN

  • Cisplatin/cisplatinum/cis-diamine dichloro platinum(II) (CDDP) – Chemotherapy drug. 
  • 1st member of platinum-containing anti-cancer drug class.
  • Administered intravenously as short-term infusion in normal saline for treatment of solid malignancies.

MECHANISM OF ACTION:

  • Following administration, one of chloride ligands is slowly displaced by water – “Aquation”.
  • Aqua ligand is easily displaced allowing platinum atoms to bind to guanine base.
  • Damaged DNA elicits DNA repair mechanisms – 
  • Inturn activate apoptosis when repair proves impossible.

DNA BINDING: 

  • Cisplatin binds to DNA & causes critical DNA structural change (bend of 45 degrees).
DOSAGE:
  • Administered slowly by i.v. infusion 50–100 mg/m2 BSA every 3–4 weeks.
  • Highly emetic drug – 
  • Antiemetics are routinely administered before infusing it. 

INDICATIONS:

Used to treat various types of cancers,

  • Sarcomas
  • Small cell lung cancer.
  • Oesophageal CA.
  • Anal squamous cell carcinoma.
  • Ovarian cancer.
  • Lymphomas.
  • Germ cell tumours
  • Thymoma
  • Dysgerminoma
  • Effective against testicular cancer & ovarian cancer.
  • Cure rate was improved from 10% to 85%
  • In carcinoma cheek – 
  • Best drug for single drug chemotherapy.
SIDE EFFECT:
  • Nephrotoxicity – Major side effect.
  • Dose-dependent toxicity.
  • Reduced by maintaining good hydration.
  • Myelotoxicity – Causes profound bone marrow suppression.
  • Hemolytic anemia – 
  • Developed after several cisplatin courses. 
  • An antibody reacting with a cisplatin-red-cell membrane responsible for hemolysis.
  • Tacrolimus toxicity
  • Neurotoxicity.
  • Nausea and vomiting
  • Most emetogenic chemotherapy agents.
  • Ototoxicity – 
  • Hearing loss.
  • Electrolyte disturbance: 
  • Causes hypomagnesaemia, hypokalemia & hypocalcaemia. 
  • Hypocalcaemia seems to occur secondary to low serum magnesium cisplatin, & not directly due to Cisplatin
  • Secondary leukaemia.
Exam Question
 
  • Chemotherapy for dysgerminoma is Cisplatin, etoposide, bleomycin.
  • Cisplatin is used in treatment of ovarian carcinoma.
  • Cisplatin is one of the most emetogenic chemotherapy agents.
  • Treatment of squamous cell carcinoma of anal canal is Cisplatin-based chemotherapy followed by radical radiotherapy.
  • Cisplatin is used in lung cancer is also used in ovarian carcinoma.
  • Important chemotherapy agent used for the thymoma treatment is Cisplatin.
  • Anticancer drug causing nephrotoxicity is cisplatin.
  • Cisplatin is associated with secondary leukaemia.
  • Cisplatin causes tacrolimus toxicity.
  • In oesophageal ca, Cisplatin is used as a Neoadjuvant chemotherapy agent.
  • Cisplatin is used in metastatic testicular carcinoma.
  • In carcinoma cheek, Cisplatin is the best drug for single drug chemotherapy.
  • Predominantly sensory neuropathy is caused by Cisplatin.
Don’t Forget to Solve all the previous Year Question asked on Cisplatin

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support